Inferior lead pseudo-infarct Q waves are a common finding in the Wolff-Parkinson-White (WPW) syndrome.The characteristic Q wave-T wave vector discordance results from secondary repolarization changes due to altered ventricular activation. As a corollary, the presence of T wave inversion with inferior lead Q waves and a short PR interval is strongly suggestive, but not pathognomonic of inferior ischemia.
Aula sobre a Síndrome de Wolff Parkinson-White , ministrada no I Simpósio Catarinense de Arritmia Cardíaca, realizado em Julho de 2017, em Florianópolis - SC.
O evento, promovido pela Clínica Ritmo, clínica especializada no tratamento de Arritmias e Implante de Marcapasso, teve como objetivo abordar todas as formas de arritmias cardíacas e as possibilidades de tratamentos, com temas trazidos a partir de casos reais tratados pelos especialistas da Clínica Ritmo nos últimos cinco anos.
Para saber mais sobre os procedimentos, acesse: http://www.clinicaritmo.com.br/
Inferior lead pseudo-infarct Q waves are a common finding in the Wolff-Parkinson-White (WPW) syndrome.The characteristic Q wave-T wave vector discordance results from secondary repolarization changes due to altered ventricular activation. As a corollary, the presence of T wave inversion with inferior lead Q waves and a short PR interval is strongly suggestive, but not pathognomonic of inferior ischemia.
Aula sobre a Síndrome de Wolff Parkinson-White , ministrada no I Simpósio Catarinense de Arritmia Cardíaca, realizado em Julho de 2017, em Florianópolis - SC.
O evento, promovido pela Clínica Ritmo, clínica especializada no tratamento de Arritmias e Implante de Marcapasso, teve como objetivo abordar todas as formas de arritmias cardíacas e as possibilidades de tratamentos, com temas trazidos a partir de casos reais tratados pelos especialistas da Clínica Ritmo nos últimos cinco anos.
Para saber mais sobre os procedimentos, acesse: http://www.clinicaritmo.com.br/
How to read ECG systematically with practice strips Khaled AlKhodari
This lecture simplifies the steps of reading ECG systematically. It starts with a simple heart anatomy and the logical steps that should be followed to perfect ECG reading without missing any abnormality. Finally, there are some practice ECG strips that include but not only MI, STEMI, Wellens syndrome, Pulmonary embolism, LVH, arrhythmias... and others
A rapid guide for short-term learning of electrocardiography history and the applications of electrocardiogram in cardiac monitoring and the diagnosis of heart pathologic conditions. Would be useful for the students who want to begin to learn this topic and the healthcare practitioners who need a review.
Another Critical Care Collaborative Deep Dive into the assessment and management of shock. Covers classification of shock, diagnosis, serial assessment methods and management.
A deep dive into management of cardiac arrhythmia from a Critical Care perspective. Covers brady- and tachyarrhythmias and management of both the stable and unstable patient.
The third presentation in my ACEM Fellowship Summary series. Focuses on the aetiology, diagnosis and management of acute heart failure in its many forms.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
2. Leads
❖ Bipolar – I, II, III
❖ Measure difference between two leads expressed in
Einthoven’s triangle
❖ Detect electrical forces in frontal plane
❖ Augmented unipolar leads – aVF, aVL, aVR
❖ Compare lead potential with centrepoint of Einthoven’s triangle
❖ Augmented to increase amplitude
❖ Praecordial leads
❖ Detect electrical forces in horizontal plane
3. Lead misplacement
❖ V leads
❖ Minor displacement of V leads of minimal significance
❖ If V1/2 too high – Inverted p wave in V2
❖ Swapping of V leads results in interruption of normal
R wave progression from V1-6
❖ Limb leads
❖ Results in significant axis changes
4. Normal ECG
❖ T wave
❖ Normally inverted or flat in v1 and aVR
❖ Inversion in V1-3 occurs in 0.5% of normal
Caucasians and has no significance if no associated
ST changes
❖ U wave
❖ Due to slow repolarisation of papillary muscles
5. Normal conduction system
❖ SA node
❖ At junction of SVC and right atrium
❖ Sinus node artery off RCA in 55% and left circumflex in 45%
❖ Normal rate 60-100
❖ Anterior, middle and posterior internodal tracts
❖ AV node
❖ Under surface of right atrial endocardium
❖ RCA supply in 90% and left circumflex in 10% (hence common AV nodal block in inferior MI)
❖ Junctional escape rhythms will occur from cells around the AV node with automaticity at sinus
rates <60 (escape rate 40-60)
❖ Bundle of His (made up of Purkinje fibres)
❖ RBBB and LBBB with left dividing into left anterior superior fascicle and left posterior inferior fascicle
6. Normal ECG
❖ Sinus rhythm (every QRS preceded by P wave)
❖ Rate 60-100bpm (300/RR interval)
❖ Axis -30 to +90
❖ PR interval 0.12-0.20s (start of P to start of QRS)
❖ QRS <0.10s (>0.12s required for BBB or ventricular rhythm diagnosis – LITFL)
❖ Bazett’s QTc = QT/(sq.r R-R)
❖ Include large incorporated U waves
❖ Exclude separate U waves
❖ Should be <0.44s in men and 0.46s in women. If >0.50s = increased risk of
TdeP
7. Measuring the QT
❖ Measure in Lead II or V5/6
❖ Maximal interval used from successive beats
❖ Large U waves >1mm fused to T wave should be
included
❖ Maximum slope method used to define end of T wave
❖ Bazett’s overcorrects at HR >100 and undercorrects at
HR <60
❖ If QRS >0.12s, subtract (QRS - 0.12) from QT
8. Measuring the QT
Prolonged ST portion (Phase 2) = Much lower risk of TdeP vs.
Prolonged T wave (Phase 3) = Much higher risk of TdeP
9. QT nomogram
❖ Utilised to ascertain risk of TdeP in drug-induced states
❖ If plotted above line = risk of TdeP
❖ 97% sensitive for predicting TdeP in poisoning; 99% specific
13. Mechanisms of conduction
disturbance
❖ Bradyarrhythmia
❖ Depression of sinus nodal activity or conduction
system blocks with subsequent subsidiary pacemaker
cells taking over at slower rates than sinus node
❖ Tachyarrhythmia
❖ 1) Increased automaticity in normal or ectopic site
❖ 2) Re-entry in a normal or accessory pathway
❖ 3) After depolarisations causing triggered rhythms
14. Increased automaticity
❖ Ectopic pacemakers can be due to:
❖ Increased automaticity of subsidiary pacemaker cells
i.e. accelerated junctional escape rhythm OR
❖ Abnormal automaticity of myocardial cells that do not
normally have pacemaking activity
❖ Either way, tends to be gradual in onset and termination
vs. re-entry abrupt
15. Re-entry arrhythmias
❖ Requires delayed conduction with subsequent
depolarisation reaching initial limb once refractory
period complete
❖ Can be around anatomically defined circuit e.g.
AVRT/AVNRT or may be disorganised through a
syncytium of myocardial tissue e.g. AF or VF
16. Triggered arrhythmias
❖ Due to oscillations of transmembrane potential during or
after repolarisation (afterpotentials)
❖ At specific rates, afterpotentials may reach threshold
causing complete depolarisation (afterdepolarisation),
which may then be self-sustaining
❖ Triggered arrhythmias associated with early
afterpotentials are enhanced by slow heart rates while
those associated with late afterpotentials are enhanced
by rapid heart rates
17. ECG Rhythms
❖ Rate
❖ Pattern - Regular, irregular (regularly or irregularly)
❖ Narrow or wide
❖ P waves absent or present
❖ AV association, dissociation or intermittent
❖ Abrupt or gradual onset
❖ Abrupt - Re-entrant vs. Gradual - Automaticity
❖ Response to vagal manoeuvre
❖ Sinus tachy, ectopic atrial tachycardia - gradual slowing but resumes
❖ AVNRT or AVRT - Abrupt stop or no effect
❖ AF or flutter - Gradual slowing
❖ VT - No response
18. Conduction block
- AV block
❖ Can be divided into nodal and infranodal block
❖ AV nodal blocks are usually due to reversible
depression of conduction, self-limited and have a stable
infranodal escape pacemaker
❖ Good prognosis
❖ AV infranodal blocks are usually due to organic disease
of the conducting system, with irreversible damage
❖ Generally slow, unstable ventricular escape rhythm
with serious prognosis
19. Conduction block
❖ First degree AV block: PR >0.20s
❖ Causes: Increased vagal tone, athletic, inferior MI, hypokalaemia, AV node blockers (beta-blockers, CCB, dig, amiodarone)
❖ No difference in mortality if no organic heart disease
❖ Second degree AV block
❖ Mobitz I (Wenckebach): Progressive prolongation. Same causes as above but usually benign. Normal property of cardiac
tissue
❖ Usually transient and seen in acute inferior MI, digoxin toxicity, myocarditis or after cardiac surgery
❖ Most common block in AMI (and portends bad prognosis)
❖ Mobitz II (P waves march through with intermittent non-conducted ones; typically have pre-existing LBBB or bifascicular block
with subsequent failure of third fascicle) - Typically structural problem and causes include anterior MI (septal), fibrosis,
cardiac surgery, rheumatic fever, SLE, amyloid, hyperkalaemia and nodal blocking drugs)
❖ Typically wide QRS due to infranodal escape rhythm
❖ If 2:1 cannot differentiate between Mobitz Type I and II but if QRS is wide, more likely infranodal block
❖ If QRS narrow (Bundle of His origin) indicates more severe disease
❖ Complete AV block - Can be end point of Mobitz I or II. Causes include inferior MI and AV nodal blocking drugs
❖ Can have nodal or infranodal complete block with narrow or wide QRS complex accordingly
❖ Most common ‘unstable’ rhythm in AMI
20. Risk
❖ Risk of complete HB in MI
❖ 1 point for each:
❖ First-degree AV block
❖ Mobitz type I 2nd degree HB
❖ Mobitz type 2 2nd degree HB
❖ LAFB
❖ LPFB
❖ RBBB
❖ LBBB
❖ Score
❖ 0 = 1.2%; 1= 7.8%, 2= 25%, 3= 36.4%
21. Conduction block
❖ AV dissociation
❖ Separate and independent pacemakers drive atria and ventricles
❖ Passive
❖ Impulse fails to reach AV node due to sinus node failure or block
❖ Escape rhythm takes over and paces ventricles
❖ When sinus node recovers, atrial activity resumes but there is often a period of independent atrial and
ventricular pacing
❖ Occurs if sinus node falls due to sinus bradycardia, sinus arrhythmia, SA block or sinus pause
❖ Causes include IHD (acute inferior MI), myocarditis, digoxin and vagal stimulation and athletes
❖ Active
❖ Slower pacemaker accelerates to usurp the sinus node to capture the ventricles with ongoing visible sinus P
waves unrelated to ventricular QRS. VT is the classic example
❖ Causes: Myocardial ischaemia, digoxin
22. Left bundle branch block
❖ Ventricular activation via RBBB, from right to left and inferior to superior
❖ QRS >0.12
❖ Loss of septal Q waves in I, V5,6
❖ Small R wave with deep S wave in II, III, aVF, V1-V3
❖ Broad monophasic R wave in I, aVL, V5, V6 = delayed ventricular activation
time in V6 (VAT)
❖ LAD
❖ Poor R wave progression
❖ Appropriate discordance: ST and T waves always go in opposite direction
to main QRS vector
❖ Causes: Aortic stenosis, IHD, HTN, dilated CM, anterior MI, hyperkalaemia,
dig toxicity, RV pacing
24. Sgarbossa criteria
❖ Used to diagnosis STEMI in LBBB and right ventricular paced
rhythms
❖ Dynamic changes are most important = serial ECG
❖ Three criteria
❖ Concordant STE >1mm in leads with positive QRS (5)
❖ Concordant ST depression >1mm in V1-3 (3)
❖ Excessively discordant ST elevation >5mm in leads with negative
QRS (2)
❖ Score of 3 or more = 90% specific for MI
25. Modified Sgarbossa Criteria
❖ 1 or more leads with >=1mm concordant ST elevation
❖ 1 or more leads of V1-3 with >=1mm of concordant ST
depression
❖ 1 or more leads with >=1mm and proportionally
excessively discordant ST elevation (>=25% of depth of
preceding S wave)
26. RBBB
❖ Ventricular activation via left bundle from left to right
❖ Usually do NOT get right axis deviation
❖ ECG criteria
❖ QRS >0.12
❖ Triphasic QRS complexes RSR’ in lead V1 (Delayed VAT in V1)
❖ Wide, slurred S waves in I, V5, V6
❖ Normal onset ventricular activation time (VAT) in V6
❖ Not necessarily deep S wave (W)
❖ Also get depolarisation issues: ST depression and T wave inversion in right precordial leads (V1-3)
❖ DDx: Normal variant, Cor pulmonale, PE, IHD, Myocarditis, Congenital HD, Ashman phenomenon,
LV pacing
28. Ashman phenomenon
❖ Wide QRS complex following a short R-R interval
preceded by a long R-R interval
❖ Seen in AF
❖ Aberrantly conducted supranodal complex rather than
one originating in either ventricle
30. Unifascicular blocks
❖ Includes LAFB, LPFB and RBBB
❖ Causes include ischaemia, cardiomyopathies, valvular
(esp. aortic), myocarditis, cardiac surgery, congenital
conditions
❖ Left posterior fascicle is far more broad and disease
indicates widespread myocardial involvement
31. Left anterior fascicle block
❖ Left axis deviation (-30 to -90 degrees)
❖ R wave in I > R wave in II and III
❖ Small q waves with tall R waves in I and aVL
❖ Small r waves with deep S waves in II, III, aVF
❖ QRS slightly prolonged (0.08-0.11s – but not >0.12)
❖ Prolonged time to R wave peak in aVL >0.045s
❖ Increased QRS voltage in limb leads
❖ May meet LVH criteria but will not show left ventricular strain
pattern
❖ Caused by AMI and LVH
33. Left posterior fascicle block
❖ Exact opposite of left anterior fascicular block
❖ Right axis deviation (+110-180 degrees)
❖ R wave in II and III > R wave in I
❖ Small r waves with deep S waves in I, aVL
❖ Small q waves with deep R waves in II, III, aVF
❖ Slightly prolonged QT
❖ Prolonged time to peak R wave >0.045s
❖ Increased QRS in limb leads
❖ Extremely rare to see this in isolation and is usually part of bifascicular block. LOOK
FOR OTHER CAUSES OF RAD (PE, tricyclic, lateral MI, right ventricular
hypertrophy)
❖ Usually associated with RBBB or septal ischaemia (usually inferior)
35. Bifascicular block
❖ RBBB + LAFB = RBBB with left axis deviation
❖ RBBB + LPFB = RBBB with right axis deviation
❖ 1% per year progress to complete heart block
37. Rate-related BBB
❖ Typically seen in diseased hearts
❖ Occurs if pacemaker depolarisations reach bundle fibres
still in their refractory period
❖ More likely to occur if prolonged refractory period in
conduction pathways i.e. sodium channel blockade
38. STEMI criteria
❖ New LBBB
❖ >2.5mm STE in V2/3 in males <40
❖ >2.0mm STE in V2/3 in males >40
❖ >1.5mm STE in V2/3 in females
❖ >1.0mm STE in all other leads
39. STEMI and STEMI
equivalents
❖ LBBB with Sgarbossa criteria (concordance!)
❖ Posterior MI: Anterior ST depression
❖ Left main coronary artery occlusion: STE in aVR and ST depression elsewhere
❖ DeWinter ST/T wave complex: 1mm ST up-sloping depression in V1-6 with
peaked T waves. Represents severe chronic LAD stenosis vs.
❖ Wellen’s syndrome: Acute LAD occlusion with deep inverted or biphasic T waves
in V2-3 (typically from biphasic to deep inverted)
❖ Criteria include normal or minimally elevated ST segment, no praecordial Q
waves, normal R wave progression, recent hx of angina, ECG pattern present in
pain free state and normal or slightly elevated troponin
❖ Hyperacute T waves
43. Infarct localisation
❖ Inferior (60%) - II, III, aVF. Reciprocal I, aVL.
❖ RCA or LCx
❖ ST elevation III > II suggestive of RCA culprit
❖ Look for STE in V1 and V4R to rule out RV involvement
(40% of inferior MI due to RCA involvement proximal to
RV)
❖ Look for inferolateral (I, aVL, V5, V6 due to LCx occlusion
in left dominance)
❖ Look for inferoposterior (ST depression V1,2)
❖ Equally present in LCx and RCA culrits
44. Infarct localisation
❖ Posterior MI
❖ Posterior myocardium not visualised, so need
reciprocal changes in V1-3
❖ Horizontal ST depression (=ST elevation)
❖ Tall, broad R waves
❖ Upright T waves (= TWI)
❖ Dominant R wave in V2 (= Q wave)
45. Infarct localisation
❖ Posterior MI (ST depression V1,2) - RCA and LCX
occlusion
❖ Look for posterolateral (STE I, aVL, V5, V6)
❖ Look for inferoposterior (STE II, III, aVF, ST
depression V1,2)
51. Pseudo-normalisation in
Wellen’s
❖ Typical pattern is anterior MI (from LAD) that may not be captured
on ECG
❖ Re-perfusion (natural or pharmacological) results in Wellen’s
pattern ECG
❖ If remains open, biphasic to deep inverted transition occurs
❖ Re-occlusion results in pseudo-normalisation of T waves and may
involve chest pain or precede it
❖ If remains occluded, get evolving anterior STEMI pattern
❖ Can have ‘stuttering’ flipping T waves
52. Pseudo-Wellens
❖ LVH causes TWI that mimics Wellens’
❖ In Wellens’, chest pain is usually resolved by the time of
ECG
❖ Wellens’ presents in V2-4 predominantly. If V3-6 TWI,
consider LVH or benign TWI
53. Benign Early Repolarisation
❖ Typically young and under 50yo
❖ Widespread concave ST elevation in V2-5
❖ Notched/slurred J point
❖ Prominent, slightly asymmetrical T waves concordant with QRS
(descending limb straighter and steeper)
❖ ST elevation <25% of T wave height in V6 (>25% suggests
pericarditis)
❖ No reciprocal ST depression (except in aVR)
❖ No dynamic changes
54. LVH criteria
❖ 25% sensitive and 85% specific
❖ Very unreliable if <40yo
❖ QRS width must be <120ms
❖ Voltage criteria + Non-voltage required
❖ Voltage criteria
❖ Sokolov-Lyon criteria = S wave depth in V1 + R wave height in V5/6 >35mm
❖ Non-voltage criteria
❖ Increased R wave peak time in V5/6 (like LAFB/LPFB)
❖ ST depression and TWI in left lateral leads (LV strain pattern)
❖ Other changes seen
❖ LA enlargement
❖ Left axis deviation
❖ ST elevation V1-3 (discordant to deep S waves)
❖ Prominent U waves
55. Right ventricular hypertrophy
❖ Right axis deviation
❖ Dominant R wave in V1 (>7mm)
❖ Dominant S wave in V5/6 (>7mm)
❖ QRS <0.12s (i.e. changes not due to RBBB)
❖ Supported by:
❖ P pulmonale
❖ RV strain (ST depression/TWI V1-4 and II/III/aVF)
❖ S1S2S3 = dominant S waves in I, II, III
❖ Deep S waves in I, aVL, V5, V6
56. VT vs. SVT with aberrancy
❖ 3 possibilities:
❖ VT/SVT with BBB/SVT with WPW
❖ In ED, 80% of broad complex tachyarrhythmia is VT
❖ Increased likelihood of VT
❖ Age >35
❖ Absence of typical RBBB/LBBB morphology
❖ Northwest axis
❖ Very broad >0.16s
❖ AV dissociation (only seen in 25% of cases) – Evidenced by canon A waves, fusion beats capture beats
❖ Capture beats (normal QRS duration amongst wide complex)
❖ Fusion beats (hybrid complex)
❖ Positive or negative concordance - All R or all QS complexes across praecordium
❖ Brugada’s sign - Onset of QRS to nadir of S wave >0.1s
❖ Josephson’s sign - Notching near nadir of S wave
❖ RSR’ with tall left rabbit ear (vs. RBBB right rabbit ear taller) - MOST SPECIFIC)
58. Brugada
❖ Phase 0 Sodium channelopathy
❖ High incidence of sudden death with structurally normal hearts
❖ Need ECG Brugada sign + Clinical to make diagnosis
❖ Coved ST elevation >2mm in 2 or more of V1-3 followed by negative T wave
❖ Clinical
❖ Documented VF or polymorphic VT
❖ FHx of sudden cardiac death <45yo
❖ Coved-type ECG in family
❖ Inducible VT
❖ Syncope
❖ Nocturnal agonal respiration
❖ Brugada type 2 and 3 are non-diagnostic
❖ Type 2 = >2mm of saddleback shaped ST elevation
❖ Type 3 = Morphology of type 1 or 2 criteria but not >2mm
60. Disposition of Brugada
❖ Brugada sign + Clinical = Admit
❖ Brugada without clinical = Cardiology Consult for
consideration of pharmacological induction or EPS
studies
❖ Type 2 or 3 with or without clinical = Cardiology Consult
for consideration of pharmacological induction or EPS
studies
❖ Normal ECG with syncope and FHx of sudden cardiac
death = Cardiology referral for provocative testing
61. Hyperkalaemia
❖ Peaked T waves
❖ Narrow-based, symmetrical, sharp apex. T >= R amplitude in more than one lead
❖ Far left axis
❖ P wave widens and flattens through to paralysis
❖ PR segment lengthens
❖ P waves eventually disappear
❖ Prolonged QRS (highest risk feature)
❖ High-grade AV block with slow escape rhythms
❖ Shortened QT
❖ Conduction blocks
❖ Sinus bradycardia
❖ Sine wave
❖ Asystole
❖ VF
❖ PEA
62. Hypokalaemia
❖ Increased amplitude of P wave
❖ Prolonged PR interval
❖ T wave flattening and inversion
❖ U wave
❖ ST depression
❖ Long QT due to long QU
❖ Frequent ectopics
❖ SVT
❖ VT/VF/TdeP
63. Hypercalcaemia
❖ Less diastolic relaxation – eventually stops in systole
❖ Shortened QTc (<350ms)
❖ Bradycardias relatively common
❖ Broad-based tall peaked T waves
❖ Wide QRS
❖ Low amplitude R waves/p waves
64. Hypocalcaemia
❖ Prolongs ST and QT intervals
❖ Narrowed QRS
❖ Shortened PR
T wave flattening and inversion
❖ ST depression
65. Prolonged QT
❖ Causes
❖ Hypokalaemia
❖ Hypomagnesaemia
❖ Hypocalcaemia
❖ Hypothermia
❖ MI
❖ Post-cardiac arrest
❖ Raised ICP
❖ Congenital long QT syndrome
❖ Medications: See next slide
66. Drug-induced prolonged QT
Drug group Drug
Antipsychotics Chlorpromazine
Haloperidol
Droperidol
Quetiapine
Olanzapine
Amisulpride
Thioridazine
Type IA anti-arrhythmics Quinidine
Procainamide
Disopyramide
Type IC anti-arrhythmics Flecainide
67. Drug-induced prolonged QT
Class III Anti-arrhythmics Sotalol
Amiodarone
TCA Amitryptiline
Doxepine
Imipramine
Nortryptiline
Desipramine
Other anti-depressants Citalopram
Escitalopram
Venlafaxine
Bupropion
Moclobemide
Antihistamines Diphenhydramine
Loratadine
Terfanadine
Other Chloroquine
Hydroxychloroquine
Quinine
Macrolides - Erythromycin,
Clarithromycin
Organophosphates
68. Long QT syndrome
❖ QTc > 470 in men and 480 in women
❖ Increased susceptibility to torsades de pointes
❖ Consider in syncope
70. Preterminal rhythms
❖ Pulseless electrical activity
❖ Organised electrical complexes without cardiac output
❖ In the setting of cardiac arrest, is due to profound
metabolic disturbance of myocardium
❖ Associated with hypovolaemia, hypoxia, acidosis,
hypo/hyperkalaemia, hypoglycaemia, hypothermia,
TCA/digoxin/CCB, beta-blocker, cardiac tamponade,
massive PE, tension pneumo/haemothorax, AMI and
ventricular wall rupture
71. Preterminal rhythms
❖ Idioventricular rhythm
❖ Ventricular escape rhythma at <40 beats/min
❖ Occurs due to complete infranodal AV block, AMI,
cardiac tamponade, exsanguinating haemorrhage
❖ Treatment is CPR if no output and adrenaline
❖ Atropine of no proven benefit (likely due to infranodal
escape and no vagal stimulation)
72. Preterminal rhythms
❖ Agonal ventricular rhythm
❖ Very broad and irregular ventricular complexes at a
slow rate without associated ventricular contractions
❖ Cardiac asystole
❖ CPR and adrenaline
❖ Transthoracic pacing sometimes induces electrical
capture but rarely yields effective output
73. Paced rhythm interpretation
❖ RV pacing (most common) causes secondary repolarisation
abnormalities of opposing polarity to the predominant QRS
complex
❖ Most leads will have predominantly negative QRS complexes
followed by ST segment elevation and positive T waves
❖ In this setting, discordant ST elevation >5mm is most
indicative of AMI in leads with predominantly negative QRS
complexes
❖ Any ST elevation concordant with QRS complexes in a
predominantly positive QRS complex is highly specific for
AMI
74. Non-ischaemic ST elevation
❖ Pericarditis
❖ Benign early repolarisation
❖ LBBB
❖ LVH
❖ Ventricular aneurysm
❖ Brugada syndrome
❖ Ventricular paced rhythm
❖ Subarachnoid haemorrhage or other causes of raised ICP
75. ST elevation in aVR
❖ Differential
❖ LMCA syndrome
❖ Triple vessel disease
❖ Proximal LAD
❖ Global hypoperfusion e.g. post-ROSC
❖ Thoracic aortic dissection
❖ Massive PE
❖ LBBB
❖ LVH
❖ Severe atrial tachydysrhythmias